Topix Pharmaceuticals

Topix was founded in 1981 and built its reputation in the physician market where it is the largest provider of premium, micro-branded and branded skincare products, partnering with over 3,000 physicians in the U.S. 

Topix’s portfolio of products are clinically-validated and manufactured in the cmpany’s state-of-the-art, FDA-registered facility in New York.

 

Topix is backed by New Mountain Capital, a growth-oriented investment firm that currently manages more than $20 billion in assets. New Mountain Capital invested in Topix in July 2016 to provide equity capital for Topix to execute a growth strategy, including both organic and acquisition-led growth.

• http://www.topixpharm.com/

Topix's family of clinical and consumer-facing brands includes Replenix™, Dr. Zenovia Skincare™, ClarityRx™, DERMA-E™, the #1 and fastest growing facial care brand in the natural channel, and Think, the highest Environmental Working Group (EWG) rated science backed clean sun care.